#Dr traverso series

In 2021 he was elected to the American Society for Clinical Investigation. In 2020 he was recognized by Wired Magazine as one of the changemakers of tomorrow who is helping build a better world. He has been the recipient of the Grand Prize of the Collegiate Inventors Competition, a Research Fellowship from Trinity College (Cambridge, UK), and was named one of the most promising innovators under 35 by the MIT Tech Review’s TR 35. Traverso’s work has been published in Science, Nature, Science Translational Medicine, Science Robotics, Science Advances, Nature Biotechnology, Nature Materials, Nature Communications, The New England Journal of Medicine, The Lancet, the Journal of the American Medical Association, and Cancer Research. Traverso’s inventions have been licensed or resulted in start-up companies that he co-founded, and some are now in active human clinical trials, all with the overarching goal of bringing his team’s inventions to help patients at the bedside.ĭr. Traverso and his team is the development of novel ingestible electronic devices, which can sense a broad array of physiologic and pathophysiologic parameters. Furthermore, they have developed a family of materials that polymerize in the GI tract for drug delivery and nutrient modulation. The group has also designed capsules that achieve self-orientation and injection of biologic drugs into the mucosa, including insulin, monoclonal antibodies and mRNA. This work is enabling the development of weekly therapy for neuropsychiatric disease, a once-a-month oral contraceptive, and capsules for the eradication of malaria. His team has developed capsules for long-term residence in the stomach (multiple weeks to months) and capacity for ultra-long drug delivery. Traverso’s research program is drug delivery systems that expand our capacity to efficiently deliver therapeutics through the gastrointestinal tract. Combining materials science, mechanical, electrical, and chemical engineering with pharmaceutical and clinical sciences, they are developing the next generation of ingestible drug delivery and sensing devices. Traverso’s current research group is highly multi-disciplinary and engaged in research at the forefront of engineering sciences.

#Dr traverso series

Robert Langer at MIT where he developed a series of technologies for drug delivery as well as physiological sensing via the gastrointestinal (GI) tract.ĭr. For his post-doctoral research, he worked in the laboratory of Prof. Traverso’s early work focused on the development of innovative molecular tests for the early detection of colon cancer and was published in The New England Journal of Medicine and The Lancet. He subsequently completed medical school training at the University of Cambridge, his internal medicine residency at BWH and his gastroenterology fellowship training at Massachusetts General Hospital, both at Harvard Medical School. Bert Vogelstein at Johns Hopkins University.

He received his BA from Trinity College, University of Cambridge, UK, and his PhD from the laboratory of Prof. Traverso grew up in Peru, Canada and the United Kingdom. Giovanni Traverso, an Assistant Professor in the Department of Mechanical Engineering at the Massachusetts Institute of Technology (MIT) and in the Division of Gastroenterology, Brigham and Women’s Hospital (BWH), Harvard Medical School.

The recipient of the 2023 Acta Biomaterialia Silver Medal is Dr.

Giovanni Traverso – 2023 Acta Biomaterialia Silver Medal Recipient